Publication Information

{'id': 'https://openalex.org/W3127073291', 'doi': 'https://doi.org/10.2217/imt-2020-0285', 'title': 'Immunotherapy in Neoadjuvant Setting in Muscle-Invasive Bladder Cancer, What’s New?', 'display_name': 'Immunotherapy in Neoadjuvant Setting in Muscle-Invasive Bladder Cancer, What’s New?', 'publication_year': 2021, 'publication_date': '2021-02-09', 'ids': {'openalex': 'https://openalex.org/W3127073291', 'doi': 'https://doi.org/10.2217/imt-2020-0285', 'mag': '3127073291', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/33557589'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.2217/imt-2020-0285', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S71887004', 'display_name': 'Immunotherapy', 'issn_l': '1750-743X', 'issn': ['1750-743X', '1750-7448'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310321119', 'host_organization_name': 'Future Medicine', 'host_organization_lineage': ['https://openalex.org/P4310321119'], 'host_organization_lineage_names': ['Future Medicine'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'editorial', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5074839123', 'display_name': 'Marwan Alkassis', 'orcid': 'https://orcid.org/0000-0002-8203-7952'}, 'institutions': [{'id': 'https://openalex.org/I184679254', 'display_name': 'Saint Joseph University', 'ror': 'https://ror.org/044fxjq88', 'country_code': 'LB', 'type': 'education', 'lineage': ['https://openalex.org/I184679254']}], 'countries': ['LB'], 'is_corresponding': False, 'raw_author_name': 'Marwan Alkassis', 'raw_affiliation_strings': ['Department of\xa0Urology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon'], 'affiliations': [{'raw_affiliation_string': 'Department of\xa0Urology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon', 'institution_ids': ['https://openalex.org/I184679254']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5009118253', 'display_name': 'Julien Sarkis', 'orcid': 'https://orcid.org/0000-0002-5060-0819'}, 'institutions': [{'id': 'https://openalex.org/I184679254', 'display_name': 'Saint Joseph University', 'ror': 'https://ror.org/044fxjq88', 'country_code': 'LB', 'type': 'education', 'lineage': ['https://openalex.org/I184679254']}], 'countries': ['LB'], 'is_corresponding': False, 'raw_author_name': 'Julien Sarkis', 'raw_affiliation_strings': ['Department of\xa0Urology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon'], 'affiliations': [{'raw_affiliation_string': 'Department of\xa0Urology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon', 'institution_ids': ['https://openalex.org/I184679254']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5037053936', 'display_name': 'Georges Abi Tayeh', 'orcid': 'https://orcid.org/0000-0002-0921-3083'}, 'institutions': [{'id': 'https://openalex.org/I184679254', 'display_name': 'Saint Joseph University', 'ror': 'https://ror.org/044fxjq88', 'country_code': 'LB', 'type': 'education', 'lineage': ['https://openalex.org/I184679254']}], 'countries': ['LB'], 'is_corresponding': False, 'raw_author_name': 'Georges Abi Tayeh', 'raw_affiliation_strings': ['Department of\xa0Urology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon'], 'affiliations': [{'raw_affiliation_string': 'Department of\xa0Urology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon', 'institution_ids': ['https://openalex.org/I184679254']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5005356941', 'display_name': 'Hampig Raphaël Kourié', 'orcid': 'https://orcid.org/0000-0002-2502-5402'}, 'institutions': [{'id': 'https://openalex.org/I184679254', 'display_name': 'Saint Joseph University', 'ror': 'https://ror.org/044fxjq88', 'country_code': 'LB', 'type': 'education', 'lineage': ['https://openalex.org/I184679254']}], 'countries': ['LB'], 'is_corresponding': False, 'raw_author_name': 'Hampig Raphael Kourie', 'raw_affiliation_strings': ['Department of\xa0Hematology-Oncology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon'], 'affiliations': [{'raw_affiliation_string': 'Department of\xa0Hematology-Oncology, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon', 'institution_ids': ['https://openalex.org/I184679254']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5113737427', 'display_name': 'Elie Nemer', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I184679254', 'display_name': 'Saint Joseph University', 'ror': 'https://ror.org/044fxjq88', 'country_code': 'LB', 'type': 'education', 'lineage': ['https://openalex.org/I184679254']}], 'countries': ['LB'], 'is_corresponding': False, 'raw_author_name': 'Elie Nemer', 'raw_affiliation_strings': ['Department of\xa0Urology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon'], 'affiliations': [{'raw_affiliation_string': 'Department of\xa0Urology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon', 'institution_ids': ['https://openalex.org/I184679254']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': None, 'has_fulltext': False, 'cited_by_count': 2, 'citation_normalized_percentile': {'value': 0.750883, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 67, 'max': 72}, 'biblio': {'volume': '13', 'issue': '6', 'first_page': '459', 'last_page': '463'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10458', 'display_name': 'Bladder and Urothelial Cancer Treatments', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10458', 'display_name': 'Bladder and Urothelial Cancer Treatments', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12695', 'display_name': 'Urinary and Genital Oncology Studies', 'score': 0.9984, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9934, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C2775910329', 'wikidata': 'https://www.wikidata.org/wiki/Q245995', 'display_name': 'Cystectomy', 'level': 4, 'score': 0.7537178}, {'id': 'https://openalex.org/C2780352672', 'wikidata': 'https://www.wikidata.org/wiki/Q504775', 'display_name': 'Bladder cancer', 'level': 3, 'score': 0.7013075}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.6889875}, {'id': 'https://openalex.org/C2780415144', 'wikidata': 'https://www.wikidata.org/wiki/Q7388582', 'display_name': 'SAINT', 'level': 2, 'score': 0.5942209}, {'id': 'https://openalex.org/C2779473830', 'wikidata': 'https://www.wikidata.org/wiki/Q1540899', 'display_name': 'MEDLINE', 'level': 2, 'score': 0.44523743}, {'id': 'https://openalex.org/C3019882237', 'wikidata': 'https://www.wikidata.org/wiki/Q2501186', 'display_name': 'Urothelial carcinoma', 'level': 4, 'score': 0.4159299}, {'id': 'https://openalex.org/C126894567', 'wikidata': 'https://www.wikidata.org/wiki/Q105650', 'display_name': 'Urology', 'level': 1, 'score': 0.40528345}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.38615358}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.36470068}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.35736996}, {'id': 'https://openalex.org/C61434518', 'wikidata': 'https://www.wikidata.org/wiki/Q932510', 'display_name': 'General surgery', 'level': 1, 'score': 0.32268083}, {'id': 'https://openalex.org/C52119013', 'wikidata': 'https://www.wikidata.org/wiki/Q50637', 'display_name': 'Art history', 'level': 1, 'score': 0.08012092}, {'id': 'https://openalex.org/C142362112', 'wikidata': 'https://www.wikidata.org/wiki/Q735', 'display_name': 'Art', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C17744445', 'wikidata': 'https://www.wikidata.org/wiki/Q36442', 'display_name': 'Political science', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C199539241', 'wikidata': 'https://www.wikidata.org/wiki/Q7748', 'display_name': 'Law', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000074322', 'descriptor_name': 'Antineoplastic Agents, Immunological', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D002295', 'descriptor_name': 'Carcinoma, Transitional Cell', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D007167', 'descriptor_name': 'Immunotherapy', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': True}, {'descriptor_ui': 'D020360', 'descriptor_name': 'Neoadjuvant Therapy', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': True}, {'descriptor_ui': 'D001749', 'descriptor_name': 'Urinary Bladder Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000074322', 'descriptor_name': 'Antineoplastic Agents, Immunological', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002295', 'descriptor_name': 'Carcinoma, Transitional Cell', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017024', 'descriptor_name': 'Chemotherapy, Adjuvant', 'qualifier_ui': 'Q000639', 'qualifier_name': 'trends', 'is_major_topic': False}, {'descriptor_ui': 'D017024', 'descriptor_name': 'Chemotherapy, Adjuvant', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017024', 'descriptor_name': 'Chemotherapy, Adjuvant', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007167', 'descriptor_name': 'Immunotherapy', 'qualifier_ui': 'Q000639', 'qualifier_name': 'trends', 'is_major_topic': False}, {'descriptor_ui': 'D007167', 'descriptor_name': 'Immunotherapy', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020360', 'descriptor_name': 'Neoadjuvant Therapy', 'qualifier_ui': 'Q000639', 'qualifier_name': 'trends', 'is_major_topic': False}, {'descriptor_ui': 'D020360', 'descriptor_name': 'Neoadjuvant Therapy', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001749', 'descriptor_name': 'Urinary Bladder Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.2217/imt-2020-0285', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S71887004', 'display_name': 'Immunotherapy', 'issn_l': '1750-743X', 'issn': ['1750-743X', '1750-7448'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310321119', 'host_organization_name': 'Future Medicine', 'host_organization_lineage': ['https://openalex.org/P4310321119'], 'host_organization_lineage_names': ['Future Medicine'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/33557589', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.46, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 30, 'referenced_works': ['https://openalex.org/W2032453242', 'https://openalex.org/W2077060392', 'https://openalex.org/W2113156769', 'https://openalex.org/W2123431502', 'https://openalex.org/W2289712604', 'https://openalex.org/W2530516001', 'https://openalex.org/W2559804019', 'https://openalex.org/W2588916311', 'https://openalex.org/W2604441970', 'https://openalex.org/W2745624257', 'https://openalex.org/W2760661635', 'https://openalex.org/W2771737095', 'https://openalex.org/W2897581535', 'https://openalex.org/W2939862456', 'https://openalex.org/W2946867117', 'https://openalex.org/W2987436342', 'https://openalex.org/W2988581606', 'https://openalex.org/W2998719569', 'https://openalex.org/W3005738019', 'https://openalex.org/W3007839305', 'https://openalex.org/W3008097151', 'https://openalex.org/W3008618884', 'https://openalex.org/W3008737262', 'https://openalex.org/W3032884379', 'https://openalex.org/W3083429069', 'https://openalex.org/W3087464965', 'https://openalex.org/W3092138236', 'https://openalex.org/W3092302767', 'https://openalex.org/W4211115520', 'https://openalex.org/W4242669880'], 'related_works': ['https://openalex.org/W4393991810', 'https://openalex.org/W3128330365', 'https://openalex.org/W3127820018', 'https://openalex.org/W3027336582', 'https://openalex.org/W2904128870', 'https://openalex.org/W2899655305', 'https://openalex.org/W2383341741', 'https://openalex.org/W2189722039', 'https://openalex.org/W2167198546', 'https://openalex.org/W2109785281'], 'abstract_inverted_index': {'ImmunotherapyVol.': [0], '13,': [1, 1292], 'No.': [2, 1266, 1289, 1293], '6': [3, 1294], 'CommentaryImmunotherapy': [4], 'in': [5, 8, 157, 166, 237, 275, 316, 377, 422, 459, 494, 528, 613, 653, 657, 688, 753, 779, 809, 915, 988, 1014, 1084, 1130, 1166, 1205, 1235, 1323, 1357, 1368, 1394, 1420], 'neoadjuvant': [6, 608, 651, 686, 716, 1078], 'setting': [7], 'muscle-invasive': [9, 212, 616, 691, 719, 852, 1240], 'bladder': [10, 108, 134, 162, 215, 618, 692, 720, 854, 991, 1133, 1173, 1208, 1241], 'cancer,': [11, 230], "what's": [12], 'new?Marwan': [13], 'Alkassis,': [14], 'Julien': [15, 37], 'Sarkis,': [16, 1246], 'Georges': [17, 49, 1249], 'Abi': [18, 50], 'Tayeh,': [19], 'Hampig': [20, 63], 'Raphael': [21, 64], 'Kourie': [22], '&': [23, 80, 1257, 1336], 'Elie': [24, 81], 'NemerMarwan': [25], 'AlkassisDepartment': [26], 'of': [27, 30, 39, 42, 53, 56, 71, 74, 83, 86, 114, 138, 160, 191, 393, 457, 650, 680, 685, 751, 841, 888, 1036, 1051, 1075, 1092, 1125, 1156, 1170, 1213, 1238, 1284, 1397, 1401, 1423], 'Urology,': [28, 40, 54, 84], 'Faculty': [29, 41, 55, 73, 85], 'Medicine,': [31, 43, 57, 75, 87], 'Saint': [32, 44, 58, 88], 'Joseph': [33, 45, 59, 89], 'University,': [34, 46, 60, 77, 90], 'Beirut,': [35, 47, 61, 78, 91], 'Lebanon,': [36, 48, 62], 'SarkisDepartment': [38], 'Tayeh': [51], 'https://orcid.org/0000-0002-0921-3083Department': [52], 'Kourie*Author': [65], 'for': [66, 189, 353, 567, 583, 589, 718, 893, 941, 1033, 1270, 1300, 1425], 'correspondence:': [67], 'E-mail': [68], 'Address:': [69], '[email protected]': [70], 'Hematology-Oncology,': [72], 'Saint-Joseph': [76], 'Lebanon': [79], 'NemerDepartment': [82], 'LebanonPublished': [92], 'Online:9': [93], 'Feb': [94], '2021https://doi.org/10.2217/imt-2020-0285AboutSectionsView': [95], 'ArticleView': [96], 'Full': [97], 'TextPDF/EPUB': [98], 'ToolsAdd': [99], 'to': [100, 755, 851, 920, 982, 1164], 'favoritesDownload': [101], 'CitationsTrack': [102], 'CitationsPermissionsReprints': [103], 'ShareShare': [104], 'onFacebookTwitterLinkedInReddit': [105], 'View': [106], 'articleKeywords:': [107], 'cancerimmunotherapyneoadjuvant': [109, 1332], 'chemotherapyPARP': [110, 1333], 'inhibitorsradiotherapyurothelial': [111, 1334], 'cancerReferences1.': [112], 'Cancer': [113, 119, 242, 727, 922, 997, 1121, 1225], 'the': [115, 158, 192, 658, 725, 784, 984, 989, 1034, 1093, 1157, 1167, 1236, 1301, 1362, 1369, 1395, 1417, 1421], 'Urinary': [116], 'Bladder': [117, 229, 257, 726, 1272], '–': [118, 1210], 'Stat': [120], 'Facts.': [121], 'SEER.': [122], '(2020).': [123, 218, 595, 1019, 1141], 'https://seer.cancer.gov/statfacts/html/urinb.html': [124], 'Google': [125, 177, 206, 247, 264, 304, 338, 366, 406, 444, 480, 516, 554, 635, 668, 704, 739, 764, 794, 824, 907, 930, 965, 1003, 1021, 1064, 1107, 1143, 1231], 'Scholar2.': [126], 'Fletcher': [127], 'A,': [128, 130, 599, 601, 671, 770, 976], 'Choudhury': [129], 'Alam': [131], 'N.': [132, 357, 573], 'Metastatic': [133], 'cancer:': [135, 163, 721, 783, 918, 1089, 1242], 'a': [136, 292, 323, 431, 469, 504, 541, 848, 953, 1044, 1214, 1243, 1354], 'review': [137, 1411], 'current': [139], 'management.': [140], 'ISRN': [141], 'Urol.': [142, 201, 698], '2011': [143], '(2011).': [144], 'www.ncbi.nlm.nih.gov/pmc/articles/PMC3197261/Google': [145], 'Scholar3.': [146], 'Stein': [147], 'JP,': [148], 'Lieskovsky': [149], 'G,': [150, 1112, 1149], 'Cote': [151], 'R': [152], 'et': [153, 185, 227, 255, 272, 312, 347, 374, 414, 452, 488, 524, 562, 604, 643, 676, 712, 747, 773, 802, 832, 881, 938, 1029, 1072, 1115, 1153, 1195], 'al.': [154, 186, 228, 256, 273, 313, 348, 375, 415, 453, 489, 525, 563, 605, 644, 677, 713, 748, 774, 803, 833, 882, 939, 1030, 1073, 1116, 1154, 1196], 'Radical': [155, 187], 'cystectomy': [156, 188, 612, 1201], 'treatment': [159, 288, 493, 1035, 1237], 'invasive': [161, 1132], 'long-term': [164], 'results': [165, 388, 429, 467, 679, 723, 887, 950], '1,054': [167], 'patients.': [168], 'J.': [169, 200, 239, 359, 436, 575, 627, 732, 867, 900, 958, 994, 1057, 1138], 'Clin.': [170, 437, 628, 733, 868, 901, 959, 996, 1058, 1139], 'Oncol.': [171, 332, 400, 438, 475, 548, 629, 734, 869, 902, 960, 1059, 1102, 1140], '19(3),': [172], '666–675': [173], '(2001).Crossref,': [174], 'Medline,': [175, 205, 263, 302, 336, 364, 404, 442, 479, 514, 552, 633, 666, 702, 763, 792, 822, 928, 1002, 1106, 1229], 'CAS,': [176, 303, 337, 365, 405, 443, 515, 553, 634, 667, 703, 793, 823, 929, 1230], 'Scholar4.': [178], 'Ghoneim': [179], 'MA,': [180], 'Abdel-Latif': [181], 'M,': [182, 640, 1024], 'el-Mekresh': [183], 'M': [184], 'carcinoma': [190, 283, 320, 380, 591, 619, 656, 693, 948], 'bladder:': [193], '2,720': [194], 'consecutive': [195], 'cases': [196], '5': [197], 'years': [198], 'later.': [199], '180(1),': [202], '121–127': [203], '(2008).Crossref,': [204], 'Scholar5.': [207], 'Professionals': [208], 'S-O.': [209], 'EAU': [210], 'guidelines:': [211], 'and': [213, 280, 455, 500, 534, 647, 843, 1128, 1276], 'metastatic': [214, 281, 318, 378, 426, 463, 501, 537, 570, 897, 916, 946], 'cancer.': [216, 258], 'Uroweb': [217], 'https://uroweb.org/guideline/bladder-cancer-muscle-invasive-and-metastatic/Google': [219], 'Scholar6.': [220], 'Flaig': [221, 877], 'TW,': [222, 878], 'Spiess': [223], 'PE,': [224], 'Agarwal': [225], 'N': [226], 'Version': [231], '3.2020,': [232], 'NCCN': [233], 'Clinical': [234, 645], 'Practice': [235], 'guidelines': [236], 'Oncology.': [238], 'Natl': [240], 'Compr.': [241], 'Netw.': [243], '18(3),': [244], '329–354': [245], '(2020).Crossref,': [246, 701, 738, 791, 821, 906, 927, 964, 1105, 1228], 'Scholar7.': [248], 'Kamat': [249], 'AM,': [250], 'Hahn': [251], 'NM,': [252], 'Efstathiou': [253], 'JA': [254], 'Lancet': [259, 298, 331, 399, 510, 547], '388(10061),': [260], '2796–2810': [261], '(2016).Crossref,': [262, 301, 335], 'Scholar8.': [265], 'Rosenberg': [266, 486, 875], 'JE,': [267, 876], 'Hoffman-Censits': [268], 'J,': [269, 341, 371, 797], 'Powles': [270, 446, 556, 637], 'T': [271], 'Atezolizumab': [274, 490], 'patients': [276, 423, 496, 530, 614, 689, 810, 857, 1052], 'with': [277, 289, 424, 497, 531, 615, 682, 690, 694, 811, 1086, 1203, 1348, 1353, 1361], 'locally': [278, 460, 498, 532, 894, 943, 1206], 'advanced': [279, 354, 461, 499, 533, 568, 781, 895, 1207], 'urothelial': [282, 319, 355, 379, 427, 464, 502, 538, 571, 590, 617, 655, 782, 815, 853, 898, 947, 990, 1171], 'who': [284, 1053], 'have': [285, 1341, 1407, 1415], 'progressed': [286], 'following': [287], 'platinum-based': [290], 'chemotherapy:': [291], 'single-arm,': [293, 505, 543, 623], 'multicentre,': [294, 324, 506, 542], 'Phase': [295, 328, 396, 433, 470, 507, 544, 624, 838, 954, 1045, 1095, 1219], 'II': [296, 508, 545, 625, 839, 955, 1046, 1096, 1220], 'trial.': [297, 330, 398, 509, 660, 786, 957, 1100], '387(10031),': [299], '1909–1920': [300], 'Scholar9.': [305], 'Sharma': [306], 'P,': [307, 933], 'Callahan': [308], 'MK,': [309], 'Bono': [310], 'P': [311], 'Nivolumab': [314], 'monotherapy': [315], 'recurrent': [317], '(CheckMate': [321], '032):': [322], 'open-label,': [325, 395, 622], 'two-stage,': [326], 'multi-arm,': [327], 'I/II': [329, 471], '17(11),': [333], '1590–1598': [334], 'Scholar10.': [339], 'Bellmunt': [340], 'de': [342, 1147], 'Wit': [343], 'R,': [344, 972, 974, 1067], 'Vaughn': [345], 'DJ': [346], 'Pembrolizumab': [349, 606], 'as': [350, 491, 607, 715, 847], 'second-line': [351], 'therapy': [352, 566, 609, 717, 1198], 'carcinoma.': [356, 572, 816, 899], 'Engl.': [358], 'Med.': [360, 576, 662, 788, 818], '376(11),': [361], '1015–1026': [362], '(2017).Crossref,': [363, 441, 478, 513, 551], 'Scholar11.': [367], 'Patel': [368], 'MR,': [369], 'Ellerton': [370], 'Infante': [372, 410], 'JR': [373], 'Avelumab': [376, 564], 'after': [381], 'platinum': [382], 'failure': [383], '(JAVELIN': [384], 'Solid': [385], 'Tumor):': [386], 'pooled': [387], 'from': [389, 430, 468, 724, 951, 1118], 'two': [390], 'expansion': [391], 'cohorts': [392], 'an': [394, 417, 621, 862, 1090], 'I': [397, 1152], '19(1),': [401], '51–64': [402], '(2018).Crossref,': [403, 632], 'Scholar12.': [407], 'Apolo': [408], 'AB,': [409], 'JR,': [411], 'Balmanoukian': [412], 'A': [413, 642, 675, 836, 1028], 'Avelumab,': [416], 'anti-programmed': [418], 'death-ligand': [419], '1': [420], 'antibody,': [421], 'refractory': [425], 'carcinoma:': [428, 465, 503], 'multicenter,': [432], 'Ib': [434], 'Study.': [435, 473, 626], '35(19),': [439], '2117–2124': [440], 'Scholar13.': [445], 'T,': [447, 557, 638], "O'Donnell": [448, 522], 'PH,': [449], 'Massard': [450], 'C': [451, 582, 1071, 1194], 'Efficacy': [454], 'safety': [456], 'durvalumab': [458, 1159], 'or': [462, 536, 569, 896, 945, 1345, 1351, 1358, 1365, 1378, 1383, 1386, 1388, 1414, 1428], 'updated': [466], 'Open-label': [472], 'JAMA': [474, 1101], '3(9),': [476], 'e172411': [477], 'Scholar14.': [481], 'Balar': [482, 518], 'AV,': [483, 519], 'Galsky': [484], 'MD,': [485], 'JE': [487], 'first-line': [492], 'cisplatin-ineligible': [495, 529, 812], '389(10064),': [511], '67–76': [512], 'Scholar15.': [517], 'Castellano': [520], 'D,': [521, 673, 968], 'PH': [523], 'First-line': [526], 'pembrolizumab': [527, 687, 892, 1076], 'unresectable': [535], 'cancer': [539, 752, 855, 992, 1042, 1134, 1174, 1209], '(KEYNOTE-052):': [540], 'study.': [546], '18(11),': [549], '1483–1492': [550], 'Scholar16.': [555], 'Park': [558], 'SH,': [559], 'Voog': [560], 'E': [561], 'maintenance': [565, 592], 'Eng.': [574], '0(0),': [577], 'null': [578], '(2020).Google': [579, 873, 1187], 'Scholar17.': [580], 'Research': [581], 'DE': [584], 'and.': [585], 'FDA': [586, 594], 'approves': [587], 'avelumab': [588], 'treatment.': [593, 993], 'www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-avelumab-urothelial-carcinoma-maintenance-treatmentGoogle': [596], 'Scholar18.': [597], 'Necchi': [598, 670], 'Anichini': [600], 'Raggi': [602, 672], 'D': [603], 'before': [610, 1199], 'radical': [611, 1200], '(PURE-01):': [620], '36(34),': [630], '3353–3360': [631], 'Scholar19.': [636], 'Kockx': [639], 'Rodriguez-Vida': [641], 'efficacy': [646, 987], 'biomarker': [648], 'analysis': [649, 1091], 'atezolizumab': [652], 'operable': [654, 813], 'ABACUS': [659], 'Nat.': [661, 787, 817], '25(11),': [663], '1706–1714': [664], '(2019).Crossref,': [665, 1001, 1063], 'Scholar20.': [669], 'Gallina': [674], 'Updated': [678], 'PURE-01': [681], 'preliminary': [683, 722, 885], 'activity': [684], 'variant': [695], 'histologies.': [696], 'Eur.': [697], '77(4),': [699], '439–446': [700], 'Scholar21.': [705], 'Wei': [706], 'XX,': [707], 'McGregor': [708], 'BA,': [709], 'Lee': [710], 'RJ': [711], 'Durvalumab': [714, 1005], 'Signal': [728, 1122], 'Seeking': [729, 1123], 'trial': [730, 840, 1221], '(BLASST)-2.': [731], '38(Suppl.': [735, 870, 903, 961], '6),': [736, 904, 962], '507–507': [737], 'Scholar22.': [740], 'Bozic': [741], 'I,': [742], 'Reiter': [743], 'JG,': [744], 'Allen': [745], 'B': [746], 'Evolutionary': [749], 'dynamics': [750], 'response': [754, 1083], 'targeted': [756], 'combination': [757, 1158], 'therapy.': [758], 'Elife': [759], '2,': [760], 'e00747': [761], '(2013).Crossref,': [762], 'Scholar23.': [765], 'van': [766], 'Dijk': [767], 'N,': [768, 799], 'Gil-Jimenez': [769], 'Silina': [771], 'K': [772], 'Preoperative': [775], 'ipilimumab': [776], 'plus': [777, 806, 891, 1077, 1160], 'nivolumab': [778], 'locoregionally': [780], 'NABUCCO': [785], '26(12),': [789, 819], '1839–1844': [790], 'Scholar24.': [795], 'Gao': [796], 'Navai': [798], 'Alhalabi': [800], 'O': [801], 'Neoadjuvant': [804, 1031], 'PD-L1': [805], 'CTLA-4': [807], 'blockade': [808], 'high-risk': [814], '1845–1851': [820], 'Scholar25.': [825], 'Grande': [826], 'E,': [827, 910, 1026], 'Guerrero': [828], 'F,': [829, 970], 'Puente': [830], 'J': [831], 'DUTRENEO': [834], 'Trial:': [835], 'randomized': [837, 1098], 'DUrvalumab': [842], 'TREmelimumab': [844], 'versus': [845], 'chemotherapy': [846, 1079], 'NEOadjuvant': [849], 'approach': [850], '(MIBC)': [856, 1135], '(pts)': [858], 'prospectively': [859], 'selected': [860], 'by': [861], 'interferon': [863], '(INF)-gamma': [864], 'immune': [865], 'signature.': [866], '15),': [871, 1061], '5012–5012': [872], 'Scholar26.': [874], 'Friedlander': [879], 'TW': [880], 'Study': [883], 'EV-103:': [884], 'durability': [886], 'enfortumab': [889], 'vedotin': [890], '441–441': [905], 'Scholar27.': [908], 'Nizialek': [909], 'Antonarakis': [911], 'ES.': [912], 'PARP': [913, 985], 'inhibitors': [914, 986], 'prostate': [917], 'evidence': [919], 'date.': [921], 'Manag.': [923], 'Res.': [924, 998], '12,': [925], '8105–8114': [926], 'Scholar28.': [931], 'Grivas': [932], 'Loriot': [934], 'Y,': [935], 'Feyerabend': [936], 'S': [937], 'Rucaparib': [940], 'recurrent,': [942], 'advanced,': [944], '(mUC):': [949], 'ATLAS,': [952], 'Open-Label': [956], '440–440': [963], 'Scholar29.': [966], 'Criscuolo': [967], 'Morra': [969], 'Giannella': [971], 'Visconti': [973], 'Cerrato': [975], 'Celetti': [977], 'A.': [978], 'New': [979], 'combinatorial': [980], 'strategies': [981], 'improve': [983], 'Exp.': [995], '38(1),': [999], '91': [1000], 'Scholar30.': [1004], 'Plus': [1006], 'Olaparib': [1007], 'Combo': [1008], 'Shows': [1009], '50%': [1010], 'Pathologic': [1011], 'Complete': [1012], 'Response': [1013], 'MIBC.': [1015], 'Targeted': [1016], 'oncology.': [1017], '1–13': [1018], 'www.targetedonc.com/view/duvalumab-plus-olaparib-combo-shows-50-pathologic-complete-response-in-mibc': [1020], 'Scholar31.': [1022], 'Provencio': [1023], 'Nadal': [1025], 'Insa': [1027], 'chemo-immunotherapy': [1032], 'stage': [1037], 'IIIA': [1038], 'resectable': [1039, 1172], 'non-small-cell': [1040], 'lung': [1041], '(NSCLC):': [1043], 'multicenter': [1047, 1218], 'exploratory': [1048], 'study-final': [1049], 'data': [1050], 'underwent': [1054], 'surgical': [1055], 'assessment.': [1056], '37(Suppl.': [1060], '8509–8509': [1062], 'Scholar32.': [1065], 'Nanda': [1066], 'Liu': [1068], 'MC,': [1069], 'Yau': [1070], 'Effect': [1074], 'on': [1080, 1297], 'pathologic': [1081], 'complete': [1082], 'women': [1085], 'early-stage': [1087], 'breast': [1088], 'ongoing': [1094], 'adaptively': [1097], 'I-SPY2': [1099], '6(5),': [1103], '676–684': [1104], 'Scholar33.': [1108], 'Gupta': [1109], 'S,': [1110], 'Sonpavde': [1111], 'Weight': [1113], 'CJ': [1114], 'Results': [1117], 'BLASST-1': [1119], '(Bladder': [1120], 'Trial)': [1124], 'nivolumab,': [1126], 'gemcitabine,': [1127], 'cisplatin': [1129], 'muscle': [1131], 'undergoing': [1136], 'cystectomy.': [1137], 'https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.6_suppl.439Crossref,': [1142], 'Scholar34.': [1144], 'Rodriguez-Moreno': [1145], 'JF,': [1146], 'Velasco': [1148], 'Bravo': [1150], 'Fernandez': [1151], 'Impact': [1155], 'olaparib': [1161], 'administer': [1162], 'prior': [1163], 'surgery': [1165], 'molecular': [1168], 'profile': [1169], ':': [1175], 'NEODURVARIB': [1176], 'Trial.': [1177], 'Presented': [1178], 'at:': [1179], 'GU': [1180], 'Cancers': [1181], 'Symposium.': [1182], 'San': [1183], 'Francisco,': [1184], 'CA,': [1185], 'USA': [1186], 'Scholar35.': [1188], 'Schmid': [1189], 'SC,': [1190], 'Koll': [1191], 'FJ,': [1192], 'Rödel': [1193], 'Radiation': [1197], 'combined': [1202], 'immunotherapy': [1204], 'study': [1211], 'protocol': [1212], 'prospective,': [1215], 'single': [1216], 'arm,': [1217], '(RACE': [1222], 'IT).': [1223], 'BMC': [1224], '20(1),': [1226], '8': [1227], 'ScholarFiguresReferencesRelatedDetailsCited': [1232], 'ByNeoadjuvant': [1233], 'immunochemotherapy': [1234], 'nonmetastatic': [1239], 'systematic': [1244], 'reviewJulien': [1245], 'Enguerrand': [1247], 'Vannier,': [1248], 'Mjaess,': [1250], 'Corentin': [1251], 'Pochet,': [1252], 'Simone': [1253], 'Albisinni,': [1254], 'Thierry': [1255, 1258], 'Quackels': [1256], 'Roumeguère30': [1259], 'November': [1260], '2022': [1261], '|': [1262, 1281], 'Immunotherapy,': [1263], 'Vol.': [1264, 1287, 1291], '14,': [1265], '17Perioperative': [1267], 'Systemic': [1268], 'Treatment': [1269], 'Muscle-Invasive': [1271], 'Cancer:': [1273], 'Current': [1274], 'Evidence': [1275], 'Future': [1277, 1329], 'Perspectives4': [1278], 'July': [1279], '2021': [1280, 1316, 1321, 1326, 1328], 'International': [1282], 'Journal': [1283], 'Molecular': [1285], 'Sciences,': [1286], '22,': [1288], '13': [1290], 'Follow': [1295], 'us': [1296], 'social': [1298], 'media': [1299], 'latest': [1302], 'updates': [1303], 'Metrics': [1304], 'Downloaded': [1305], '164': [1306], 'times': [1307], 'History': [1308], 'Received': [1309], '26': [1310], 'October': [1311], '2020': [1312], 'Accepted': [1313], '29': [1314], 'January': [1315], 'Published': [1317, 1322], 'online': [1318], '9': [1319], 'February': [1320], 'print': [1324], 'April': [1325], 'Information©': [1327], 'Medicine': [1330], 'LtdKeywordsbladder': [1331], 'cancerFinancial': [1335], 'competing': [1337], 'interests': [1338], 'disclosureThe': [1339], 'authors': [1340, 1403], 'no': [1342], 'relevant': [1343], 'affiliations': [1344], 'financial': [1346, 1355, 1359], 'involvement': [1347], 'any': [1349], 'organization': [1350], 'entity': [1352], 'interest': [1356], 'conflict': [1360], 'subject': [1363], 'matter': [1364], 'materials': [1366], 'discussed': [1367], 'manuscript.': [1370], 'This': [1371], 'includes': [1372], 'employment,': [1373], 'consultancies,': [1374], 'honoraria,': [1375], 'stock': [1376], 'ownership': [1377], 'options,': [1379], 'expert': [1380], 'testimony,': [1381], 'grants': [1382], 'patents': [1384], 'received': [1385], 'pending,': [1387], 'royalties.No': [1389], 'writing': [1390], 'assistance': [1391], 'was': [1392], 'utilized': [1393], 'production': [1396], 'this': [1398], 'manuscript.Ethical': [1399], 'conduct': [1400], 'researchThe': [1402], 'state': [1404], 'that': [1405], 'they': [1406], 'obtained': [1408], 'appropriate': [1409], 'institutional': [1410], 'board': [1412], 'approval': [1413], 'followed': [1416], 'principles': [1418], 'outlined': [1419], 'Declaration': [1422], 'Helsinki': [1424], 'all': [1426], 'human': [1427], 'animal': [1429], 'experimental': [1430], 'investigations.PDF': [1431], 'download': [1432]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3127073291', 'counts_by_year': [{'year': 2022, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 1}], 'updated_date': '2025-01-05T06:31:45.463735', 'created_date': '2021-02-15'}